placeholder image
V. R. Aroda All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Correlation between time in range and HbA1c in people with type 2 diabetes on basal insulin: post hoc analysis of the SWITCH PRO study. 
    Diabetes Therapy. 2023
  • Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles. 
    Journal of Diabetes Science and Technology. 2022
  • Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia. 
    Diabetes, Obesity & Metabolism. 2021
  • Reproducibility of a prediabetes classification in a contemporary population. 
    Metabol Open. 2020
  • Establishing an electronic health record-supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: the vitamin D and type 2 diabetes (D2d) study experience. 
    Clinical Trials (London, England). 2019
  • Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen. 
    Diabetes Technology & Therapeutics. 2019
  • Vitamin D supplementation and prevention of type 2 diabetes. 
    New England Journal of Medicine. 2019
  • Baseline characteristics of the Vitamin D and type 2 Diabetes (D2d) study: a contemporary prediabetes cohort that will inform diabetes prevention efforts. 
    Diabetes care. 2018
  • Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. 
    Diabetes, Obesity & Metabolism. 2017
  • Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: The LixiLan-L randomized trial. 
    Diabetes care. 2016
    • Conference Poster
  • Optimizing basal-bolus therapy in T2D—a randomized controlled trial comparing bolus insulin delivery using an insulin patch vs. an insulin pen [poster]
    2018
    • Abstract
  • Efficacy and safety of the insulin glargine plus lixisenatide fixed-ratio combination vs. insulin glargine in patients wth T2DM: the LixiLan-L trial [abstract]. 
    Diabetes. 2016
    • Contact
    full name
  • V. R. Aroda
    • Quick Info
     
    Collaboration